Boston Scientific Balance Sheet Health
Financial Health criteria checks 4/6
Boston Scientific has a total shareholder equity of $20.2B and total debt of $10.6B, which brings its debt-to-equity ratio to 52.6%. Its total assets and total liabilities are $36.7B and $16.5B respectively. Boston Scientific's EBIT is $2.5B making its interest coverage ratio 10.2. It has cash and short-term investments of $2.3B.
Key information
52.6%
Debt to equity ratio
US$10.61b
Debt
Interest coverage ratio | 10.2x |
Cash | US$2.33b |
Equity | US$20.17b |
Total liabilities | US$16.50b |
Total assets | US$36.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BSXC's short term assets ($8.2B) exceed its short term liabilities ($4.9B).
Long Term Liabilities: BSXC's short term assets ($8.2B) do not cover its long term liabilities ($11.6B).
Debt to Equity History and Analysis
Debt Level: BSXC's net debt to equity ratio (41.1%) is considered high.
Reducing Debt: BSXC's debt to equity ratio has reduced from 99.9% to 52.6% over the past 5 years.
Debt Coverage: BSXC's debt is well covered by operating cash flow (23.3%).
Interest Coverage: BSXC's interest payments on its debt are well covered by EBIT (10.2x coverage).